Preterm Birth Prevention and Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175132 | Category: Pharma & Healthcare | Pages: 67 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.
This report aims to provide a comprehensive presentation of the global market for Preterm Birth Prevention and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preterm Birth Prevention and Treatment. This report contains market size and forecasts of Preterm Birth Prevention and Treatment in global, including the following market information:
Global Preterm Birth Prevention and Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Preterm Birth Prevention and Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Progesterone Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Preterm Birth Prevention and Treatment include AMAG Pharmaceuticals, Ferring Pharmaceutical, Teva, Allergan, AbbVie, Aurobindo Pharma, Bayer, Mylan and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preterm Birth Prevention and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preterm Birth Prevention and Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, by Type, 2022 (%)
    Progesterone Therapy
    Corticosteroid Therapy
    Tocolytics Therapy
    Antihypertensive Therapy
    Magnesium Sulfate Therapy
    Other
Global Preterm Birth Prevention and Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Drugs Stores
    Other
Global Preterm Birth Prevention and Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preterm Birth Prevention and Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Preterm Birth Prevention and Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AMAG Pharmaceuticals
    Ferring Pharmaceutical
    Teva
    Allergan
    AbbVie
    Aurobindo Pharma
    Bayer
    Mylan
    Pfizer
    Merck & Co
    Novartis
    Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preterm Birth Prevention and Treatment, market overview.
Chapter 2: Global Preterm Birth Prevention and Treatment market size in revenue.
Chapter 3: Detailed analysis of Preterm Birth Prevention and Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preterm Birth Prevention and Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Preterm Birth Prevention and Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Preterm Birth Prevention and Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Preterm Birth Prevention and Treatment Overall Market Size
    2.1 Global Preterm Birth Prevention and Treatment Market Size: 2022 VS 2029
    2.2 Global Preterm Birth Prevention and Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Preterm Birth Prevention and Treatment Players in Global Market
    3.2 Top Global Preterm Birth Prevention and Treatment Companies Ranked by Revenue
    3.3 Global Preterm Birth Prevention and Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Preterm Birth Prevention and Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Preterm Birth Prevention and Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Preterm Birth Prevention and Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Preterm Birth Prevention and Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Preterm Birth Prevention and Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Preterm Birth Prevention and Treatment Market Size Markets, 2022 & 2029
        4.1.2 Progesterone Therapy
        4.1.3 Corticosteroid Therapy
        4.1.4 Tocolytics Therapy
        4.1.5 Antihypertensive Therapy
        4.1.6 Magnesium Sulfate Therapy
        4.1.7 Other
    4.2 By Type - Global Preterm Birth Prevention and Treatment Revenue & Forecasts
        4.2.1 By Type - Global Preterm Birth Prevention and Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Preterm Birth Prevention and Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Preterm Birth Prevention and Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Preterm Birth Prevention and Treatment Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Drugs Stores
        5.1.4 Other
    5.2 By Application - Global Preterm Birth Prevention and Treatment Revenue & Forecasts
        5.2.1 By Application - Global Preterm Birth Prevention and Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Preterm Birth Prevention and Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Preterm Birth Prevention and Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Preterm Birth Prevention and Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Preterm Birth Prevention and Treatment Revenue & Forecasts
        6.2.1 By Region - Global Preterm Birth Prevention and Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Preterm Birth Prevention and Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Preterm Birth Prevention and Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Preterm Birth Prevention and Treatment Revenue, 2018-2029
        6.3.2 US Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.3.3 Canada Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.3.4 Mexico Preterm Birth Prevention and Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Preterm Birth Prevention and Treatment Revenue, 2018-2029
        6.4.2 Germany Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.3 France Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.4 U.K. Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.5 Italy Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.6 Russia Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.4.8 Benelux Preterm Birth Prevention and Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Preterm Birth Prevention and Treatment Revenue, 2018-2029
        6.5.2 China Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.5.3 Japan Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.5.4 South Korea Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.5.6 India Preterm Birth Prevention and Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Preterm Birth Prevention and Treatment Revenue, 2018-2029
        6.6.2 Brazil Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.6.3 Argentina Preterm Birth Prevention and Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Preterm Birth Prevention and Treatment Revenue, 2018-2029
        6.7.2 Turkey Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.7.3 Israel Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Preterm Birth Prevention and Treatment Market Size, 2018-2029
        6.7.5 UAE Preterm Birth Prevention and Treatment Market Size, 2018-2029
7 Preterm Birth Prevention and Treatment Companies Profiles
    7.1 AMAG Pharmaceuticals
        7.1.1 AMAG Pharmaceuticals Company Summary
        7.1.2 AMAG Pharmaceuticals Business Overview
        7.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Major Product Offerings
        7.1.4 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.1.5 AMAG Pharmaceuticals Key News & Latest Developments
    7.2 Ferring Pharmaceutical
        7.2.1 Ferring Pharmaceutical Company Summary
        7.2.2 Ferring Pharmaceutical Business Overview
        7.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Major Product Offerings
        7.2.4 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.2.5 Ferring Pharmaceutical Key News & Latest Developments
    7.3 Teva
        7.3.1 Teva Company Summary
        7.3.2 Teva Business Overview
        7.3.3 Teva Preterm Birth Prevention and Treatment Major Product Offerings
        7.3.4 Teva Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.3.5 Teva Key News & Latest Developments
    7.4 Allergan
        7.4.1 Allergan Company Summary
        7.4.2 Allergan Business Overview
        7.4.3 Allergan Preterm Birth Prevention and Treatment Major Product Offerings
        7.4.4 Allergan Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.4.5 Allergan Key News & Latest Developments
    7.5 AbbVie
        7.5.1 AbbVie Company Summary
        7.5.2 AbbVie Business Overview
        7.5.3 AbbVie Preterm Birth Prevention and Treatment Major Product Offerings
        7.5.4 AbbVie Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.5.5 AbbVie Key News & Latest Developments
    7.6 Aurobindo Pharma
        7.6.1 Aurobindo Pharma Company Summary
        7.6.2 Aurobindo Pharma Business Overview
        7.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Major Product Offerings
        7.6.4 Aurobindo Pharma Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.6.5 Aurobindo Pharma Key News & Latest Developments
    7.7 Bayer
        7.7.1 Bayer Company Summary
        7.7.2 Bayer Business Overview
        7.7.3 Bayer Preterm Birth Prevention and Treatment Major Product Offerings
        7.7.4 Bayer Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.7.5 Bayer Key News & Latest Developments
    7.8 Mylan
        7.8.1 Mylan Company Summary
        7.8.2 Mylan Business Overview
        7.8.3 Mylan Preterm Birth Prevention and Treatment Major Product Offerings
        7.8.4 Mylan Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.8.5 Mylan Key News & Latest Developments
    7.9 Pfizer
        7.9.1 Pfizer Company Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Preterm Birth Prevention and Treatment Major Product Offerings
        7.9.4 Pfizer Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.9.5 Pfizer Key News & Latest Developments
    7.10 Merck & Co
        7.10.1 Merck & Co Company Summary
        7.10.2 Merck & Co Business Overview
        7.10.3 Merck & Co Preterm Birth Prevention and Treatment Major Product Offerings
        7.10.4 Merck & Co Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.10.5 Merck & Co Key News & Latest Developments
    7.11 Novartis
        7.11.1 Novartis Company Summary
        7.11.2 Novartis Business Overview
        7.11.3 Novartis Preterm Birth Prevention and Treatment Major Product Offerings
        7.11.4 Novartis Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.11.5 Novartis Key News & Latest Developments
    7.12 Sanofi
        7.12.1 Sanofi Company Summary
        7.12.2 Sanofi Business Overview
        7.12.3 Sanofi Preterm Birth Prevention and Treatment Major Product Offerings
        7.12.4 Sanofi Preterm Birth Prevention and Treatment Revenue in Global Market (2018-2023)
        7.12.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Preterm Birth Prevention and Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?